Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience

HCV treatment became available for all infected patients regardless of their comorbidities, especially for HIV coinfected subjects, leading to an improvement in both clinical and immunological conditions. We retrospectively analyzed a cohort of HIV/HCV coinfected patients treated with DAA therapies;...

Descripción completa

Detalles Bibliográficos
Autores principales: Marino, Andrea, Zafarana, Gabriella, Ceccarelli, Manuela, Cosentino, Federica, Moscatt, Vittoria, Bruno, Gabriele, Bruno, Roberto, Benanti, Francesco, Cacopardo, Bruno, Celesia, Benedetto Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700507/
https://www.ncbi.nlm.nih.gov/pubmed/34943573
http://dx.doi.org/10.3390/diagnostics11122336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700507/
https://www.ncbi.nlm.nih.gov/pubmed/34943573
http://dx.doi.org/10.3390/diagnostics11122336

Ejemplares similares